Product image of Neoduplamox Bambini (Aroma Frutti Misti) (Amoxicillin, Clavulanic Acid) supplied by GNH India

Neoduplamox Bambini (Aroma Frutti Misti)

Active Ingredient:
Amoxicillin, Clavulanic Acid
Origin:
EU

Neoduplamox Bambini (Aroma Frutti Misti) (Amoxicillin, Clavulanic Acid)

Amoxicillin, the active ingredient in Neoduplamox Bambini (Aroma Frutti Misti), is a penicillin beta‑lactamase inhibitor combination presented as an oral suspension for pediatric use. It treats bacterial infections such as otitis media, sinusitis, pneumonia, urinary tract and skin infections in children.

GNH India supplies Neoduplamox Bambini (Aroma Frutti Misti) as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable logistics and timely delivery to meet patient needs.

Manufacturer / TM Owner

Neopharmed Gentili Spa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Neoduplamox Bambini (amoxicillin/clavulanic acid) is used to treat bacterial infections of the respiratory, urinary and skin systems.

  • Acute otitis media: reduces bacterial load, relieving ear pain and inflammation.
  • Sinusitis: eradicates causative pathogens and improves sinus drainage.
  • Community‑acquired pneumonia: combats the infecting organisms and supports recovery of lung function.
  • Urinary tract infections: eliminates uropathogens and alleviates urinary symptoms.
  • Skin and soft tissue infections: clears bacterial involvement and promotes healing of affected skin.

How It Works

  • Amoxicillin inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, while clavulanic acid irreversibly blocks β‑lactamase enzymes produced by resistant bacteria, thereby restoring amoxicillin’s activity and extending its antibacterial spectrum.

Side Effects

Adverse reactions to Neoduplamox Bambini may vary in frequency and severity.

Common Side Effects

  • Diarrhea: loose stools that may be mild to moderate.
  • Nausea: feeling of stomach discomfort or urge to vomit.
  • Rash: mild skin redness or itching.
  • Vomiting: expulsion of stomach contents.
  • Abdominal pain: cramping or discomfort in the stomach area.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction with breathing difficulty and swelling.
  • Clostridioides difficile‑associated diarrhea: severe colitis presenting with watery stools.
  • Liver enzyme elevation: increased ALT or AST indicating hepatic stress.
  • Stevens‑Johnson syndrome: rare skin blistering and mucosal involvement.
  • Neutropenia: marked reduction in white blood cells increasing infection risk.

Precautions & Warnings

Before prescribing Neoduplamox Bambini, consider the following precautions.

  • Assess allergy history: avoid in patients with known penicillin or clavulanic acid hypersensitivity.
  • Monitor renal function: dose adjustment may be required in impaired kidney function.
  • Evaluate hepatic status: use caution in patients with liver disease.
  • Observe for superinfection: prolonged use can lead to fungal or bacterial overgrowth.
  • Use with caution in the elderly: increased risk of adverse reactions.
  • Store at room temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Neoduplamox Bambini can interact with several medicines; categorize them as follows.

Major Interactions (Avoid)

  • Probenecid: may increase amoxicillin plasma concentrations, raising toxicity risk.
  • Methotrexate: can reduce clearance, leading to enhanced methotrexate toxicity.
  • Warcoma: may potentiate anticoagulant effect and increase bleeding risk.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: antibiotic may reduce efficacy, consider additional contraception.
  • Allopurinol: combined use may increase risk of skin rash.
  • Ciprofloxacin: concurrent use may heighten seizure risk in susceptible individuals.

Frequently Asked Questions

Neoduplamox Bambini is a pediatric formulation of amoxicillin/clavulanic acid indicated for the treatment of bacterial infections such as acute otitis media, sinusitis, community‑acquired pneumonia, urinary tract infections, and skin and soft‑tissue infections in children.

Amoxicillin interferes with bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, while clavulanic acid blocks β‑lactamase enzymes that some bacteria produce to inactivate amoxicillin, thereby extending the antibiotic’s spectrum of activity.

The prescribed dose of Neoduplamox Bambini is set by the treating clinician based on the child’s age, weight, severity of infection, and renal function. No fixed dosing regimen is provided here; the prescriber tailors therapy to each patient.

Safety data for amoxicillin/clavulanic acid in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified health professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Neoduplamox combines a broad‑spectrum penicillin with a β‑lactamase inhibitor, offering coverage against many β‑lactamase‑producing organisms that may be resistant to amoxicillin alone. Compared with macrolides or quinolones, it provides a different resistance profile and is often preferred for first‑line pediatric use when susceptibility is confirmed.

Neoduplamox Bambini should be stored at room temperature, below 25 °C, in its original container. Protect the suspension from moisture, direct sunlight and excessive heat to maintain stability and potency.

The product is an oral suspension intended for pediatric patients. It is taken by mouth, usually with or without food, as directed by the prescribing clinician. The exact volume and frequency depend on the individual’s prescribed regimen.

Serious adverse events include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, hepatic enzyme elevations, Stevens‑Johnson syndrome, and neutropenia. Immediate medical attention is required if any of these symptoms develop.

Patients with a documented hypersensitivity to amoxicillin, clavulanic acid, or any other penicillin‑class antibiotics should avoid Neoduplamox Bambini. Caution is also advised for individuals with severe renal or hepatic impairment, and the drug should be used only under medical supervision in such cases.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.